ABP-745

· Atom Therapeutics Co., Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABP-745, covering 2025-08-17 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis [Phase 2]